New patent expiration for Medicure drug AGGRASTAT
Annual Drug Patent Expirations for AGGRASTAT Aggrastat is a drug marketed by Medicure and is included in two NDAs. It […]
New patent expiration for Medicure drug AGGRASTAT Read Post »
Annual Drug Patent Expirations for AGGRASTAT Aggrastat is a drug marketed by Medicure and is included in two NDAs. It […]
New patent expiration for Medicure drug AGGRASTAT Read Post »
Annual Drug Patent Expirations for CLINDESSE Clindesse is a drug marketed by Padagis Us and is included in one NDA.
New patent expiration for Padagis Us drug CLINDESSE Read Post »
Annual Drug Patent Expirations for FOTIVDA Fotivda is a drug marketed by Aveo Pharms and is included in one NDA.
New patent expiration for Aveo Pharms drug FOTIVDA Read Post »
CLINDESSE (clindamycin phosphate) Padagis us Patent: 6,899,890 Expiration: Apr 27, 2023 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of April 23, 2023 Read Post »
Annual Drug Patent Expirations for DUTREBIS Dutrebis is a drug marketed by Merck Sharp Dohme and is included in one
New patent expiration for Merck Sharp drug DUTREBIS Read Post »
Annual Drug Patent Expirations for DUTREBIS Dutrebis is a drug marketed by Merck Sharp Dohme and is included in one
New patent expiration for Merck Sharp drug DUTREBIS Read Post »
Annual Drug Patent Expirations for ISENTRESS+HD Isentress Hd is a drug marketed by Msd Sub Merck and is included in
New patent expiration for Msd Sub drug ISENTRESS HD Read Post »
Annual Drug Patent Expirations for ISENTRESS Isentress is a drug marketed by Msd Sub Merck and is included in three
New patent expiration for Msd Sub drug ISENTRESS Read Post »
Annual Drug Patent Expirations for TESTIM Testim is a drug marketed by Auxilium Pharms Llc and is included in one
New patent expiration for Auxilium Pharms drug TESTIM Read Post »
Get fresh news and insights, drug patent expirations & more…